相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Vaccine Technologies Essential Components of an Adequate Response to Emerging Viral Diseases
Barney S. Graham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Optimization of multiple satisfaction levels in portfolio decision analysis
Maria Barbati et al.
OMEGA-INTERNATIONAL JOURNAL OF MANAGEMENT SCIENCE (2018)
Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
Daniela S. Rajao et al.
FRONTIERS IN MICROBIOLOGY (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
Dimitrios Gouglas et al.
LANCET GLOBAL HEALTH (2018)
Portfolio decision analysis methods in environmental decision making
Tuomas J. Lahtinen et al.
ENVIRONMENTAL MODELLING & SOFTWARE (2017)
New Vaccines against Epidemic Infectious Diseases
John-Arne Rottingen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature
Maarten J. IJzerman et al.
PHARMACOECONOMICS (2017)
The complexity and cost of vaccine manufacturing - An overview
Stanley Plotkin et al.
VACCINE (2017)
Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
Sarah C. Gilbert et al.
VACCINE (2017)
A robust algorithm for project portfolio selection problem using real options valuation
Mahsa Montajabiha et al.
INTERNATIONAL JOURNAL OF MANAGING PROJECTS IN BUSINESS (2017)
An Open Innovation Decision Support System to Select a Biopharmaceutical R&D Portfolio
Giovanna Lo Nigro et al.
MANAGERIAL AND DECISION ECONOMICS (2016)
Heuristic solution approaches to the pharmaceutical R&D pipeline management problem
Brianna Christian et al.
COMPUTERS & CHEMICAL ENGINEERING (2015)
Emerging Viral Diseases: Confronting Threats with New Technologies
Hilary D. Marston et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Multicriteria Portfolio Modeling for the Development of Shared Action Agendas
Eeva Vilkkumaa et al.
GROUP DECISION AND NEGOTIATION (2014)
A mathematical model for maximizing the value of phase 3 drug development portfolios incorporating budget constraints and risk
Nitin R. Patel et al.
STATISTICS IN MEDICINE (2013)
Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
F. Reed Johnson et al.
VALUE IN HEALTH (2013)
Multiobjective strategies for New Product Development in the pharmaceutical industry
Jose L. Perez-Escobedo et al.
COMPUTERS & CHEMICAL ENGINEERING (2012)
The current challenges for vaccine development
Petra Oyston et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
U.S. MEDICAL COUNTERMEASURE DEVELOPMENT SINCE 2001: A LONG WAY YET TO GO
Philip K. Russell et al.
BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE (2012)
R&D pipeline management: Task interdependencies and risk management
Matthew Colvin et al.
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH (2011)
The gold industry standard for risk and cost of drug and vaccine development revisited
E. S. Pronker et al.
VACCINE (2011)
Valuation of project portfolios: An endogenously discounted method
Juan C. Zapata et al.
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH (2010)
Structuring resource allocation decisions: A framework for building multi-criteria portfolio models with area-grouped options
Gilberto Montibeller et al.
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH (2009)
Portfolio analysis and R&D decision making
Richard Evans et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Strategic biopharmaceutical portfolio development: An analysis of constraint-induced implications
Edmund D. George et al.
BIOTECHNOLOGY PROGRESS (2008)
Impact of tactical and operational policies in the selection of a new product portfolio
Juan Carnilo Zapata et al.
COMPUTERS & CHEMICAL ENGINEERING (2008)
A framework for addressing stochastic and combinatorial aspects of scheduling and resource allocation in pharmaceutical R&D pipelines
Vishal A. Varma et al.
COMPUTERS & CHEMICAL ENGINEERING (2008)
Stochastic Combinatorial Optimization Approach to Biopharmaceutical Portfolio Management
Edmund D. George et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2008)
Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing
Lawrence D. Phillips et al.
ANNALS OF OPERATIONS RESEARCH (2007)
Preference programming for robust portfolio modeling and project selection
Juuso Liesio et al.
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH (2007)
Building systems to support development of drugs for biodefense
Katherine A. Taylor
DRUG DEVELOPMENT RESEARCH (2007)
Optimal decision indices for R&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index
Michael A. Talias
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH (2007)
A fuzzy set approach for R&D portfolio selection using a real options valuation model
Juite Wang et al.
OMEGA-INTERNATIONAL JOURNAL OF MANAGEMENT SCIENCE (2007)
Integrated approach to improving the value potential of biopharmaceutical R&D portfolios while mitigating risk
Anuradha Rajapakse et al.
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY (2006)
Mean-Gini analysis in R&D portfolio selection
JL Ringuest et al.
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH (2004)
The challenge of emerging and re-emerging infectious diseases
DM Morens et al.
NATURE (2004)
Managing a portfolio of interdependent new product candidates in the pharmaceutical industry
GE Blau et al.
JOURNAL OF PRODUCT INNOVATION MANAGEMENT (2004)
Simulation-optimization framework for stochastic optimization of R&D pipeline management
D Subramanian et al.
AICHE JOURNAL (2003)
Real options based analysis of optimal pharmaceutical research and development portfolios
MJ Rogers et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2002)
Dynamic portfolio selection of NPD programs using marginal returns
CH Loch et al.
MANAGEMENT SCIENCE (2002)
A portfolio-evaluation framework for selecting R&D projects
CF Chien
R & D MANAGEMENT (2002)
Evaluating growth options as sources of value for pharmaceutical research projects
CH Loch et al.
R & D MANAGEMENT (2001)
Steering a course through the technology maze
T Peakman et al.
DRUG DISCOVERY TODAY (2000)
分享论文
